Cameron Turtle

Cameron Turtle

Chief Business Officer, Eidos Therapeutics and SVP, Portfolio Management and Corporate Development, BridgeBio Pharma

• Cameron Turtle, DPhil, is the Chief Business Officer of Eidos Therapeutics.
• He was a consultant in McKinsey & Company’s Silicon Valley office, where he worked with biotech, pharmaceutical, and medical product companies on strategy for mergers and acquisitions, due diligence, growth and clinical trial strategy, and commercial operations.
• Turtle earned his DPhil in Cardiovascular Medicine as a Rhodes Scholar at the University of Oxford and his B.S. in Bioengineering from the University of Washington.